Drug Topics

MAY 15, 2025

Investigators report that patients experience weight loss with a reduced weekly dosage of the glucagon-like peptide-1 (GLP-1).

Dosage 315

Dosage 315

STAT

MAY 15, 2025

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. Summit Therapeutics’ China vs. U.S. data showdown Dare I call it the most important study readout coming this summer? I’m referring to the pending announcement of the first clinical data from Summit Therapeutics and its buzzy PD-1-VEGF antibody ivonescimab derived from lung cancer patients in the U.S. and othe

96

96

Drug Topics

MAY 15, 2025

NBC News Medical Analyst Vin Gupta, MD, joins Drug Topics at NCPDP 2025 to discuss the technological evolution of the pharmacy profession.

281

281

STAT

MAY 15, 2025

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning! Despite believing that headlines on STAT stories are “terrible,” former FDA head Robert Califf said at yesterday’s Summit that we’re “providing a tremendous service right now to the country by really interrogating what’s been called radical transparency.

FDA 88

FDA 88

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmaceutical Technology

MAY 15, 2025

The FDA has approved MSDs Welireg for rare adrenal tumours, and AbbVies Emrelis for treating c-Met+ lung cancer patients.

FDA 76

FDA 76

STAT

MAY 15, 2025

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Spare a thought for the House lawmakers and staff on two committees who suffered through markups that ran through the night.

Insurance 83

Insurance 83

Pharma Marketing Network

MAY 15, 2025

In a world of podcasts , reels, and AI-written content, its fair to ask: are white papers still pulling their weight in pharma marketing? For teams navigating omnichannel campaigns, strict MLR approvals, and buyer fatigue, the answer isn’t just “yes”it’s if done right, they work better than ever. Once the domain of technical audiences and B2B legacy brands, white papers have evolved.

52

52

Hospital Pharmacy Europe

MAY 15, 2025

One in three pharmacists in Great Britain (34%) are now independent prescribers, according to recent data from the General Pharmaceutical Council (GPhC). As of 31 March 2025, some 21,804 pharmacists now have an independent prescriber annotation, representing33% of all registered pharmacists in Great Britain, the data shows. However, the number of independent prescribers varies across England, Wales and Scotland.

Community Pharmacies 52

Community Pharmacies Hospitals Patient Care 52

The Thyroid Pharmacist

MAY 15, 2025

If youre a woman, its likely that youve experienced a urinary tract infection (UTI) at some point in your life. Some of us might even experience them more frequently than wed like (if thats you keep reading!). Between 50 and 60 percent of women will experience at least one UTI in their lifetime, and the prevalence of UTIs increases as we age. [1] In fact, its the most common outpatient infection in the U.S.

Immunization 58

Immunization Compounding Labelling 58

Fierce Healthcare

MAY 15, 2025

The CMS, within the HHS, wants feedback on how it can develop better digital health tools for Medicare beneficiaries and drive adoption.

56

56

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

MAY 15, 2025

Cure Rare Disease's CRD-002 receives FDA orphan drug designation, advancing hope for SCA3 treatment with innovative oligonucleotide therapy.

FDA 122

FDA 122

The FDA Law Blog

MAY 15, 2025

Hyman, Phelps & McNamara, P.C. is pleased to announce that Sophia Gaulkin will be presenting and speaking on an expert panel at Informa Connectsannual Life Sciences Pricing & Contracting USA Summit , which is being held virtually and in-person in Philadelphia on May 19-21. Ms. Gaulkins presentation, Product Price Increases: A SPTR Practical Walkthrough , will provide an interactive case study outlining the hypothetical enforcement, appeal, and settlement scenarios that may apply to quali

FDA 59

FDA 59

PharmExec

MAY 15, 2025

Welireg marks the first FDA-approved non-surgical treatment option for locally advanced, unresectable, or metastatic pheochromocytoma or paraganglioma in patients over 12 years of age.

FDA 52

FDA 52

Pharmaceutical Technology

MAY 15, 2025

From predictive analytics to robotic warehousing, automation is unlocking new efficiencies in pharma logistics.

52

52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

MAY 15, 2025

Iodine Software's pre-bill solution can identify an extra 25% revenue savings per month for health systems after a patient is discharged. The savings could help justify investment in other AI products.

45

45

Pharmaceutical Technology

MAY 15, 2025

The US Food and Drug Administration (FDA) has accepted BioCryst Pharmaceuticals new drug application (NDA) for Orladeyo.

FDA 52

FDA 52

The Checkup by Singlecare

MAY 15, 2025

Ivermectin is a generic prescription medication that is approved by the Food and Drug Administration ( FDA ) to treat certain parasitic infections , such as intestinal strongyloidiasis and onchocerciasis. Without insurance, the cost of ivermectin is $157 for 20, 3 mg tablets. While there arent any over-the-counter alternatives available for ivermectin , you can lower the price of an ivermectin prescription in many ways.

Insurance 52

Insurance Mail-Order Pharmacies Insurance Coverage Dosage 52

Pharma Times

MAY 15, 2025

Aspire-FTD study aims to stop disease progression with one-time treatment

33

33

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

MAY 15, 2025

Explore the latest advancements in RSV vaccination strategies for newborns, focusing on maternal immunization and post-birth protection options.

Vaccines 65

Vaccines Immunization 65

Pharmaceutical Technology

MAY 15, 2025

Boehringer Ingelheim has entered a multi-year partnership with Tempus AI to progress its cancer treatment pipeline.

52

52

Pharmacy Times

MAY 15, 2025

The FDA approves retifanlimab for advanced anal cancer, offering new hope with improved survival rates and treatment options for patients.

FDA 65

FDA 65

STAT

MAY 15, 2025

For the first time, scientists say they have reached into the genome of a severely ill child and rewritten the unique misspelling in his DNA.  The results, published in the New England Journal of Medicine on Thursday, are a landmark in the 50-year quest to read and repair the code of life. The boy, a now 9.5-month-old named KJ, was diagnosed days after birth with an ultra-rare disease that impairs his liver’s ability to process ammonia, which can build up and cause permanent brain da

145

145

Pharmacy Times

MAY 15, 2025

Ibrutinib offers comparable survival outcomes for high-risk chronic lymphocytic leukemia patients, challenging traditional prognostic markers in real-world settings.

65

65

The Checkup by Singlecare

MAY 15, 2025

Wegovy (semaglutide) is a once-weekly weight-loss medication that belongs to a class of drugs called GLP-1 agonists. It is FDA approved for weight management and to reduce the risk of stroke, heart attack , or other cardiovascular death in people who are overweight or have obesity. Wegovy is self-injected at home, so users must know how to properly store their single-dose injector pens before use.

FDA 52

FDA 52

Pharmacy Times

MAY 15, 2025

Combining olaparib with neoadjuvant chemotherapy enhances survival rates for early-stage gBRCAm triple-negative breast cancer, offering new hope for patients.

Chemotherapy 65

Chemotherapy 65

The FDA Law Blog

MAY 15, 2025

By John W.M. Claud & Deborah L. Livornese Dr. Marty Makary took the stage on Thursday at the Food and Drug Law Institutes Annual Conference , continuing the tradition of Commissioners speaking at this event, but with a tone and tempo distinctly his own. Now firmly in the chair after the agencys controversial RIFswhich he was quick to remind everyone he did not initiateCommissioner Makary said that the FDAs future depends on rebuilding its culture, empowering its staff, and applying his visi

FDA 59

FDA Vaccines 59

Pharmacy Times

MAY 15, 2025

In patients with synchronous metastatic colorectal cancer treated without curative intent, high low-density lipoprotein (LDL) cholesterol was associated with poor survival.

65

65

Pharmaceutical Commerce

MAY 15, 2025

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

52

52

Pharmacy Times

MAY 15, 2025

Logan Schneider, MD, highlights the importance of integrating patient-reported outcomes into clinical trials to better capture the full therapeutic impact of low-sodium oxybate (Xywav) beyond traditional sleep metrics.

65

65

Drug Topics

MAY 15, 2025

Abbotts continuous glucose monitoring system is the first to show a reduction in cardiovascular complication severity.

Hospitals 389

Hospitals 389

PharmaVoice

MAY 15, 2025

Amy Parison, who stepped into the lead financial role at the company in March, is managing Editas Medicine’s transition to a new gene editing platform while recovering from a major overhaul.

147

147

Drug Topics

MAY 15, 2025

Attorneys from The Phoenix Law Group joined Drug Topics at NCPDP 2025 to discuss the current state of pharmacy benefit manager reform and where it may end up in the near future.

346

346

STAT

MAY 15, 2025

I always knew Elizabeth Holmes would have a second act. But I’m shocked it’s starting while she’s still behind bars. Elizabeth is now serving an 11-year sentence for defrauding investors in Theranos and has been banned from participating in federal health programs. The company was built on her claim that, at 19 years old, she had invented a device capable of running hundreds of tests from just a single drop of blood.

144

144